Tris(2,3-dibromopropyl)isocyanurate, also known as TDBPI, is a brominated flame retardant that has been widely used in various materials, including polymers, textiles, and electronics. It is synthesized through the reaction of cyanuric chloride with 2,3-dibromopropanol. TDBPI is highly effective in preventing the spread of flames due to its ability to release bromine radicals during combustion, which interrupt the chain reaction of the flame. However, concerns have arisen regarding its potential toxicity and environmental persistence. Studies have shown that TDBPI can accumulate in the environment and potentially pose risks to human health and wildlife. Its persistence and potential bioaccumulation have led to its phase-out or restriction in many countries. Research on TDBPI focuses on its environmental fate and transport, toxicity to various organisms, and alternative flame retardants. The study of TDBPI is crucial to understand its environmental impact, develop safer alternatives, and protect human health and ecosystems.'
tris(2,3-dibromopropyl)isocyanurate: Flame Retardant; RN, structure in first source
ID Source | ID |
---|---|
PubMed CID | 103634 |
SCHEMBL ID | 26874 |
MeSH ID | M0537035 |
Synonym |
---|
tris(2,3-dibromopropyl) isocyanurate, 97% |
einecs 257-913-4 |
1,3,5-tris(2,3-dibromopropyl)-1,3,5-triazinane-2,4,6-trione |
52434-90-9 |
I0355 |
isocyanuric acid tris(2,3-dibromopropyl) ester |
tris(2,3-dibromopropyl) isocyanurate |
FT-0640069 |
tris-(2,3-dibromopropyl)isocyanurate |
1,3,5-triazine-2,4,6(1h,3h,5h)-trione, 1,3,5-tris(2,3-dibromopropyl)- |
1,3,5-tris(2,3-dibromopropyl)-1,3,5-triazine-2,4,6(1h,3h,5h)-trione |
tris(2,3-dibromopropyl)isocyanurate |
AKOS015901131 |
hexahydro-1,3,5-tris(2,3-dibromopropyl)-1,3,5-triazine-2,4,6-trione |
SCHEMBL26874 |
1,3,5-tris(2,3-dibromopropyl)-1,3,5-triazinane-2,4,6-trione # |
NZUPFZNVGSWLQC-UHFFFAOYSA-N |
DTXSID9052713 |
tri(2,3-dibromopropyl) isocyanate |
W-105826 |
mfcd00010290 |
tris-dibromopropyisocyanate |
SB73273 |
tris(2,3-dibromopropyl)-s-triazine-2,4,6-trione |
BS-49290 |
CS-0327079 |
F71233 |
tris-dibromopropylisocyanurate |
Excerpt | Reference | Relevance |
---|---|---|
" Our results also indicated that mitochondria are one of the major target cytoplasmic organelles for TBC, suggesting that damage in mitochondria is one of the pathways that led to toxic effects in the liver and lung of TBC-treated groups." | ( Toxicity of new emerging pollutant tris-(2,3-dibromopropyl) isocyanurate on BALB/c mice. Bao, J; Li, J; Liang, Y; Liu, Y; Zhang, A; Zhang, J; Zhang, X, 2015) | 0.42 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.56) | 29.6817 |
2010's | 17 (94.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.88) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 18 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |